Sign In  |  Register  |  About Corte Madera  |  Contact Us

Corte Madera, CA
September 01, 2020 10:27am
7-Day Forecast | Traffic

  • Search Hotels in Corte Madera

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about RHHBF

Recent news which mentions RHHBF

< Previous 1 2 3 4 5 Next >
Roche's Evrysdi Shows Long-Term Efficacy, Safety In Broader Spinal Muscular Atrophy Population
Tickers PTCT RHHBF RHHBY RHHVF
Tags PTCT RHHBY RHHBF
From Benzinga
Exelixis Will Not Pursue Untreated Liver Cancer Indication For Cabometyx Combo Therapy
Tickers BAYRY BAYZF EXEL IPSEY
Tags Health Care BAYZF General
From Benzinga
Sanofi-Regeneron's Dupixent Falls Short In Chronic Spontaneous Urticaria Trial
Tickers ANY NVS REGN RHHBF
Tags Briefs SNY RHHBF
From Benzinga
Roche Expects Slower FY22 Sales Growth On Lower Demand For COVID-19 Tests
Tickers NVS RHHBF RHHBY RHHVF
Tags Earnings RHHBF Briefs
From Benzinga
Novartis Expects FY22 Sales, Profit Growth; Sandoz Review Continues
Tickers NVS RHHBF RHHBY RHHVF
Tags RHHBY NVS Guidance
From Benzinga
Biogen Exercises Option To Participate Developing Genentech's Bispecific Antibody, Mosunetuzumab
Tickers BIIB RHHBF RHHBY RHHVF
Tags Follicular Lymphoma Biotech BIIB
From Benzinga
FDA Approves First Injectable Eye Medicine For Vision Loss Disorder - Genentech's Vabysmo
Tickers RHHBF RHHBY RHHVF
Tags Diabetic Macular Edema FDA RHHBY
From Benzinga
Genentech's Evrysdi Application Under FDA Priority Review For Use In Babies Below 2 Months
Tickers RHHBF RHHBY RHHVF
Tags General Biotech News
From Benzinga
CMS Proposes Coverage Of Biogen's Alzheimer's Drug, With Conditions Apply
Tickers BIIB ESALF ESALY LLY
Tags Trading Ideas Biotech ESALF
From Benzinga
Lineage, Genentech Ink Cell Therapy Licensing Pact For Ocular Diseases
Tickers LCTX RHHBF RHHBY RHHVF
Tags Trading Ideas Biotech Long Ideas
From Benzinga
Novartis Launches New Share Buyback Program Of Up To $15B
Tickers NVS RHHBF RHHBY RHHVF
Tags why it's moving Buybacks NVS
From Benzinga
After Roche Walks Away, Atea Puts Break On Late-Stage COVID-19 Oral Antiviral Trial
Tickers AVIR RHHBF RHHBY RHHVF
Tags Briefs RHHBF News
From Benzinga
Roche's Polivy Combo Boosts Survival In Early-Stage Lymphoma Patients
Tickers RHHBF RHHBY RHHVF
Tags Health Care Phase 3 Trial ASH21
From Benzinga
Roche Uncorks Favorable Responses From Mosunetuzumab In Follicular Lymphoma Settings
Tickers RHHBF RHHBY RHHVF
Tags Market News RHHVF Benzinga
From Benzinga
Infinity Pharma Shares Updated Eganelisib Combo Therapy In Breast Cancer Trial
Tickers BMY INFI RHHBF RHHBY
Tags Market News RHHVF Benzinga
From Benzinga
Roche Posts Encouraging Follow-up Data From Tiragolumab/Tecentriq Trial In Lung Cancer
Tickers RHHBF RHHBY RHHVF
Tags Biotech Non/Small Cell Lung Cancer Benzinga
From Benzinga
Europe Approves Roche's Tocilizumab For Patients With Severe COVID-19
Tickers RHHBF RHHBY RHHVF
Tags Benzinga RHHVF Market News
From Benzinga
Immunocore' ImmTAC Candidate Shows Early Response In Ovarian And Head & Neck Cancer Patients
Tickers IMCR RHHBF RHHBY RHHVF
Tags Briefs RHHBF News
From Benzinga
Biden's New COVID-19 Plan Includes Reimbursement For Over The Counter, At-Home COVID Tests
Tickers ABT BDX CI CVS
Tags UNH Diagnostics CI
From Benzinga
Gene Therapy-Focused Dyno Therapeutics Adds Astellas To List Partner List With $1.6B Pact
Tickers ALPMF ALPMY NVS RHHBF
Tags RHHBY NVS Benzinga
From Benzinga
Roche's Gavreto Conditionally Approved In Europe For RET Fusion-Positive Lung Cancer
Tickers RHHBF RHHBY RHHVF
Tags Health Care News General
From Benzinga
Novartis Has $21B From Roche Stake Sale - Which Company Is On Its M&A Radar?
Tickers ALNY BIIB BMRN DRNA
Tags Long Ideas NTLA NVO
From Benzinga
Spark Therapeutics' Hemophilia Gene Therapy Shows Reduction In Bleeding Episodes
Tickers RHHBF RHHBY RHHVF
Tags Benzinga gene therapy RHHVF
From Benzinga
Atea Shares Plunge As Roche Culls Partnership To Develop COVID-19 Pill
Tickers AVIR RHHBF RHHBY RHHVF
Tags RHHBY Small Cap COVID/19 Coronavirus
From Benzinga
Europe Approves Regeneron - Roche's COVID-19 Antibody Cocktail
Tickers REGN RHHBF RHHBY RHHVF
Tags General News Health Care
From Benzinga
EU Regulator Backs Regeneron-Roche's COVID-19 Drug
Tickers REGN RHHBF RHHBY RHHVF
Tags News General Health Care
From Benzinga
Hit By Slow Rollout, Biogen's Aduhelm Could Soon Find Itself In Price Competition: Reuters
Tickers BIIB LLY RHHBF RHHBY
Tags Health Care News General
From Benzinga
ALX Oncology Falls After Updated Data For Solid Tumors Candidate
Tickers ALXO MRK RHHBF RHHBY
Tags Health Care Movers MRK
From Benzinga
Regeneron-Roche's COVID-19 Treatment Shows Long Term Benefit After Single Dose
Tickers REGN RHHBF RHHBY RHHVF
Tags News General Health Care
From Benzinga
Novartis To Offload Its Stake Back To Roche For $20.7B
Tickers NVS RHHBF RHHBY RHHVF
Tags RHHBF Briefs Health Care
From Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 CorteMadera.com & California Media Partners, LLC. All rights reserved.